HOME >> BIOLOGY >> NEWS
Actonel significantly reduced moderate and severe vertebral fractures

San Antonio, TX (September 20, 2002) A new analysis of scientific data presented at today's meeting of the American Society for Bone and Mineral Research (ASBMR) showed that a 5 mg dose of Actonel (risedronate sodium tablets) daily significantly reduced moderate and severe vertebral fracture risk by 70 percent within one year in postmenopausal women with osteoporosis. Furthermore, the significant effect on vertebral fracture risk was sustained over three years.

This analysis combined data from two large Actonel clinical trials, VERT-NA and VERT-MN, which included postmenopausal women with either one prevalent vertebral fracture and low bone mineral density (BMD), or with at least two prevalent vertebral fractures. The objective of this analysis was to compare the incidence of moderate or severe vertebral fracture at one year in women who received Actonel or placebo. Fracture severity was determined using the fracture severity scoring system developed by Harry Genant, M.D., Professor of Radiology, Medicine, Epidemiology and Orthopaedic Surgery at the University of California, San Francisco, an investigator and pioneer of the assessment method used in the analysis.

Recent studies show severity of prevalent vertebral fractures is a predictor of future vertebral and non-vertebral fracture risk; patients with more severe baseline vertebral fractures are more likely to experience subsequent vertebral and non-vertebral fractures. Therefore, reducing the incidence of moderate or severe vertebral fractures may help decrease the risk of future fractures.

"The ultimate goal of osteoporosis treatment is to prevent fractures," said Dr. Genant, "These new findings, combined with previous Actonel clinical data showing reductions in both risk of first vertebral fracture and multiple vertebral fractures, suggest that Actonel reduces fracture risk across a range of osteoporotic severity."

According to
'"/>


20-Sep-2002


Page: 1 2 3 4

Related biology news :

1. Rare mutations can significantly increase risk factor for heart disease
2. Cancer health risk significantly underestimated by EPAs ambient model estimates
3. Double mastectomies significantly lower risk of breast cancer in women who are genetically at risk
4. HAART therapy significantly prolongs survival in AIDS patients with central nervous system lymphoma
5. ENBREL rapidly, significantly improved back pain, mobility, function in ankylosing spondylitis
6. Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
7. Cognitive abilities increase significantly with time in most prematurely born children
8. Combining key ingredients of vegetarian diet cuts cholesterol significantly, says study
9. Pollen productionand allergiesmay rise significantly over next 50 years
10. Brain size in premature infants significantly smaller than full-term babies
11. Multicenter study shows Benecol spread significantly reduces cholesterol levels in patients taking statin drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2019)... ... April 24, 2019 , ... Noblis, Inc., a leading ... patent 10,191,929, “Systems and Methods for SNP Analysis and Genome Sequencing.” Noblis’ new ... variety of advanced bioinformatic analyses, including SNP calling, metagenomic analysis, and conserved and ...
(Date:4/17/2019)... ... 17, 2019 , ... Quartesian LLC, a full-service contract research ... has entered into a multi-year agreement with Medrio, a leading provider of eClinical ... Certified Partner Program, to leverage the full range of Medrio’s products including EDC, ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... 50 Healthcare Technology CEOs of 2019 . An extensive process was run to ... medical devices, biotech, healthcare analytics, healthcare software and other related areas. We gathered ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... 2019 , ... On April 24th, the Federal Laboratory Consortium ... for Environmental Health Research (USACEHR), with an award for their cooperative effort in ... company located at the Frederick Innovative Technology Center, Inc. (FITCI) on Metropolitan Court, ...
(Date:4/15/2019)... ... April 15, 2019 , ... ... construction of a $2 million bench plant expansion to increase production of methylene ... in the design and construction of Sirrus’ full-scale production facility, which is scheduled ...
(Date:4/10/2019)... (PRWEB) , ... April 10, ... ... both regenerative medicine manufacturing technology leaders, have locked into multiple agreements to ... before. Companies across the regenerative medicine industry, ranging from synthetic biology companies ...
(Date:4/9/2019)... Calif. (PRWEB) , ... April 09, 2019 , ... ... services firm focused on increasing the capacity of life sciences organizations to accelerate ... Cloud Assurance platform in the past 12 months. , USDM’s ...
Breaking Biology Technology:
Cached News: